We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

0HNC Biomarin Pharmaceutical Inc

0.00 (0.00%)
21 Feb 2024 - Closed
Delayed by 15 minutes

Biomarin Pharmaceutical Financial Summary

The current 0HNC market cap is 16.83B. The company's latest EPS is USD 0.7515 and P/E is 117.76.

Year End 31 December 2022 20182019202020212022
Total Revenue 1.49B1.7B1.86B1.85B2.1B
Operating Income -174.08M-126.04M-96.27M-20.41M41.56M
Net Income -77.21M-23.85M859.1M-2.15M141.56M
Year End 31 December 2022 20182019202020212022
Total Assets 4.43B4.69B5.85B6B6.38B
Total Liabilities 1.46B1.57B1.74B1.73B1.77B
Total Equity 2.97B3.12B4.11B4.27B4.6B

Cash Flow

Year End 31 December 2022 20182019202020212022
Operating 20.21M48.26M85.37M304.54M175.9M
Investing 264.35M-31.03M-53.62M-366.31M-20.03M
Financing -388.01M-74.67M181.12M-48k-18.65M
Market Cap 16.83B
Price to Earnings Ratio 117.76
Price to Sales Ratio 7.95
Price to Cash Ratio 23.01
Price to Book Ratio 3.62
Dividend Yield -

Share Statistics

Shares Outstanding 188.37M
Average Volume (1 week) 1.34k
Average Volume (1 Month) 11.34k
52 Week Change 0.00%
52 Week High 89.36
52 Week Low 89.36
Spread (Intraday) 0 (0%)

Company Info

Company Name Biomarin Pharmaceutical Inc
Address 251 little falls drive
wilmington, delaware 19808
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 |